PYSZCZYMUKA GREG 4
4 · AYTU BIOPHARMA, INC · Filed Mar 31, 2025
Insider Transaction Report
Form 4
PYSZCZYMUKA GREG
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Shares
2025-03-31+209→ 23,602 total - Exercise/Conversion
Restricted Stock Units
2025-03-31−209→ 0 total→ Common Shares (209 underlying)
Footnotes (1)
- [F1]Restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted on March 31, 2022, and vest quarterly beginning March 31, 2023 and ending March 31, 2025.